🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Efficacy Of Hiatal Closure For GERD

Recruitingn/aAges 18 Years - 50 YearsAllUniversity of Chicago
NCT06280664 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this protocol is to study the efficacy of hiatal closure for early GERD disease. The study team hypothesizes that hiatal closure for early GERD disease is an efficacious treatment of GERD.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age 18 - 50 years * Able to provide informed consent * BMI \<30 * Hiatal defect \<4cm on esophagram * pH testing requirement: pH \<4 for \>5.5% * Surgical candidate for hiatal closure only Exclusion Criteria: * Vulnerable subjects (children, prisoners, pregnant women) will be excluded.
💊

What it tests

  • Not listed
📍

Where

1 site
The University of Chicago
Chicago, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy